Endoscopic treatment of primary grade V vesicoureteral reflux using hyaluronic acid copolymer (DX/HA)

被引:8
作者
Hunziker, Manuela [2 ]
Mohanan, Nochiparambil [1 ]
D'Asta, Federica [2 ]
Puri, Prem [1 ,2 ]
机构
[1] Our Ladys Hosp Sick Children, Childrens Res Ctr, Dublin 12, Ireland
[2] Natl Childrens Hosp, Dublin, Ireland
关键词
Vesicoureteral reflux; Endoscopic treatment; Renal scarring; MANAGEMENT;
D O I
10.1007/s00383-010-2650-1
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Since DX/HA was approved by the Food and Drug Administration in 2001 as an acceptable tissue-augmenting substance for subureteral injection, endoscopic treatment has become increasingly popular for treating vesicoureteral reflux (VUR). However, most paediatric urologists still continue to recommend ureteral reimplantation as the treatment of choice in the management of grade V VUR. The purpose of this study was to prospectively evaluate the effectiveness of endoscopic subureteral injection of DX/HA in the treatment of grade V reflux. During 2001-2009, 56 children (35 males, 21 females) with primary grade V VUR underwent endoscopic treatment using DX/HA. Their ages ranged from 4 months to 11 years. Forty-nine patients had unilateral grade V VUR, and seven had bilateral grade V (63 refluxing ureters including 17 duplex systems). Renal scarring on dimercaptosuccinic acid was observed in 39 kidneys (mild scarring 13, moderate scarring 14 and severe scarring 12). In all patients, endoscopic injection was made after inserting the needle within the wide ureteral orifice. Renal ultrasound and voiding cystourethrogram was performed 3 months after the endoscopic treatment. If VUR had not resolved, the patient was considered for further endoscopic treatment. After the VUR was resolved, children were followed with renal ultrasound at 1 year and every 2 years thereafter. The VUR completely resolved after first injection of DX/HA in 33 (52.4%) ureters and downgraded to grade I VUR in 7 (11.1%) ureters. 19 (30.2%) ureters required a second injection, and 4 (6.3%) ureters required a third injection to resolve VUR. No children in this series needed reimplantation of ureters or presented with ureteral obstruction during follow-up. Endoscopic treatment with DX/HA is effective in eradicating grade V primary reflux. This simple and minimally invasive treatment should be offered to all parents of children with grade V VUR as an alternative to ureteral reimplantation.
引用
收藏
页码:977 / 979
页数:3
相关论文
共 50 条
  • [21] Endoscopic treatment with dextranomer/hyaluronic acid for complex cases of vesicoureteral reflux
    Perez-Brayfield, M
    Kirsch, AJ
    Hensle, TW
    Koyle, MA
    Furness, P
    Scherz, HC
    JOURNAL OF UROLOGY, 2004, 172 (04) : 1614 - 1616
  • [22] Endoscopic treatment of vesicoureteral reflux with dextranomer/hyaluronic acid copolymer is effective in either double ureters or a small kidney
    Läckgren, G
    Wåhlin, N
    Sköldenberg, E
    Nevéus, T
    Stenberg, A
    JOURNAL OF UROLOGY, 2003, 170 (04) : 1551 - 1555
  • [23] Appearance of Dextranomer/Hyaluronic Acid Copolymer Implants on Computerized Tomography After Endoscopic Treatment of Vesicoureteral Reflux in Children
    Cerwinka, Wolfgang H.
    Qian, Jing
    Easley, Kirk A.
    Scherz, Hal C.
    Kirsch, Andrew J.
    JOURNAL OF UROLOGY, 2009, 181 (03) : 1324 - 1328
  • [24] Dextranomer/Hyaluronic Acid Endoscopic Injection is Effective in the Treatment of Intermediate and High Grade Vesicoureteral Reflux in Patients with Complete Duplex Systems
    Hunziker, Manuela
    Mohanan, Nochiparambil
    Puri, Prem
    JOURNAL OF UROLOGY, 2013, 189 (05) : 1876 - 1880
  • [25] Endoscopic Treatment of Primary Vesicoureteral Reflux
    Diamond, David A.
    Mattoo, Tej K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (13) : 1218 - 1226
  • [26] Endoscopic injection of dextranomer/hyaluronic acid copolymer to correct vesicoureteral reflux following failed ureteroneocystostomy
    Kitchens, David
    Minevich, Eugene
    DeFoor, William
    Reddy, Pramod
    Wacksman, Jeffrey
    Sheldon, Curtis
    Koyle, Martin
    JOURNAL OF UROLOGY, 2006, 176 (04) : 1861 - 1863
  • [27] Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux:: Histological findings
    Stenberg, A
    Larsson, E
    Läckgren, G
    JOURNAL OF UROLOGY, 2003, 169 (03) : 1109 - 1113
  • [28] Dextranomer-Hyaluronic Acid and Polyacrylate-Polyalcohol Copolymer are Equally Efficient for Endoscopic Treatment of Vesicoureteral Reflux in Children
    Bele, Uros
    Bratus, Dejan
    UROLOGY JOURNAL, 2019, 16 (04) : 361 - 365
  • [29] A Comparison Between Dextranomer/Hyaluronic Acid and Polyacrylate Polyalcohol Copolymer as Bulking Agents for Treating Primary Vesicoureteral Reflux
    Alizadeh, Farshid
    Omidi, Iman
    Haghdani, Saeid
    Khorrami, Mohammad Hatef
    Izadpanahi, Mohammad Hossein
    Sichani, Mehrdad Mohammadi
    UROLOGY JOURNAL, 2019, 16 (02) : 174 - 179
  • [30] Early Results of Endoscopic Treatment of Vesicoureteral Reflux with Polyacrylate Polyalcohol Copolymer
    Sencan, Arzu
    Ucan, Basak
    Evciler, Huseyin
    Serdaroglu, Erkin
    Hosgor, Munevver
    UROLOGIA INTERNATIONALIS, 2014, 92 (02) : 219 - 222